Clinical Trials

Accrual Status
Limit to SWOG Trials

647 Results

View
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0816

A Phase II Trial of Response-Adapted Therapy of Stage III-IV Hodgkin Lymphoma using Interim FDG-PET Imaging
Research Committee(s)
Lymphoma
Activated
07-01-2009
Closed
12-01-2012
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0701

A Phase III Randomized Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori
Research Committee(s)
Prevention & Epidemiology
Activated
06-16-2009
Closed
06-30-2010
ClinicalTrials.gov Registry Number
NCT01061437
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0802

A Randomized Phase II Trial of Weekly Topotecan with and without AVE0005 (Aflibercept; NSC-724770) in Patients with Platinum Treated Extensive Stage Small Cell Lung Cancer (E-SCLC)
Research Committee(s)
Lung Cancer
Activated
05-15-2009
Closed
03-01-2012
Closed
Phase
Accrual
94%
Published
SWOG Clinical Trial Number
S0713

A Phase II Study of Oxaliplatin, Capecitabine, Cetuximab and Radiation in Pre-operative Therapy of Rectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
02-01-2009
Closed
04-15-2013
ClinicalTrials.gov Registry Number
NCT00686166
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0702

"A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients with Bone Metastases Starting Zoledronic Acid Treatment"
Status Notes
Status Notes: NOTE: The url for ordering specimen kits for this study has changed. Please use the following link: https://ricapps.nationwidechildrens.org/KitManagement
Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Genitourinary Cancer
Lung Cancer
Myeloma
Activated
12-15-2008
Closed
12-13-2013
ClinicalTrials.gov Registry Number
NCT00874211
Closed
Phase
Accrual
93%
Published
SWOG Clinical Trial Number
S0703

A Phase II Trial of Azacitidine Plus Gemtuzumab Ozogamicin as Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia
Status Notes
Research Committee(s)
Leukemia
Activated
12-01-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0809

A Phase II Trial of Adjuvant Capecitabine/Gemcitabine Chemotherapy Followed by Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma (EHCC)
Research Committee(s)
Gastrointestinal Cancer
Activated
12-01-2008
Closed
10-01-2012
ClinicalTrials.gov Registry Number
NCT00789958
Closed
Phase
Accrual
54%
Published
SWOG Clinical Trial Number
S0709

A Phase II Selection Design of Pharmacodynamic Separation of Carboplatin/Paclitaxel/OSI-774 (Erlotinib; NSC-718781) or OSI-774 Alone in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients with Performance Status 2 (PS-2) Selected by Serum Proteomics
Research Committee(s)
Lung Cancer
Activated
12-01-2008
Closed
09-15-2014
ClinicalTrials.gov Registry Number
NCT00661193
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0722

A Phase II Trial of mTOR Inhibitor, Everolimus, (RAD001) in Malignant Pleural Mesothelioma (MPM)
Research Committee(s)
Lung Cancer
Activated
12-01-2008
Closed
09-15-2011
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0720

Phase II ERCC 1 and RRM1-Based Adjuvant Therapy Trial in Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)
Research Committee(s)
Lung Cancer
Activated
11-15-2008
Closed
05-15-2012
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0000D

S0000D, "A Study of the Effect of Vitamin E and/or Selenium on Adenomatous Colorectal Polyps (ACP) in Participants Enrolled in SELECT, Phase III Ancillary to S0000-SELECT
Activated
06-03-2008
Closed
05-28-2013
ClinicalTrials.gov Registry Number
NCT00706121
Closed
Phase
Accrual
2%
Published
SWOG Clinical Trial Number
S0502

A Phase III Randomized Study of Imatinib, with or without Bevacizumab (NSC-704865), in Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-2008
Closed
10-01-2009
ClinicalTrials.gov Registry Number
NCT00324987
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0777

A Randomized Phase III Trial of CC-5013 (lenalidomide, NSD-703813) and Low Dose Dexamethasone (LLD) versus Bortezomib (PS-341, NSC-681239), Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction, in Patients with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant
Status Notes
Revision #24 requires sites to contact all patients that have been enrolled, including those that have completed treatment and follow-up, to offer them participation in extended follow-up.
Research Committee(s)
Myeloma
Activated
04-01-2008
Closed
02-01-2012
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0727

A Phase I and Randomized Phase II Trial of Gemcitabine + Erlotinib (NSC-718781) + IMC-A12 (NSC-742460) vs. Gemcitabine + Erlotinib as First Line Treatment in Patients with Metastatic Pancreatic Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
03-01-2008
Closed
09-01-2010
ClinicalTrials.gov Registry Number
NCT00617708
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0518

Phase III Prospective Randomized Comparison of Depot Octreotide plus Interferon Alpha versus Depot Octreotide plus Bevacizumab (NSC #704865) in Advanced, Poor Prognosis Carcinoid Patients
Research Committee(s)
Gastrointestinal Cancer
Activated
12-01-2007
Closed
09-01-2012
ClinicalTrials.gov Registry Number
NCT00569127
Closed
Phase
Accrual
91%
Published
SWOG Clinical Trial Number
S0438

A Randomized Phase II Trial of BAY 43-9006 (Sorafenib; NSC-724772) with Either CCI-779 (Temsirolimus; NSC-683864) or R115777 (Tipifarnib; NSC-702818) in Metastatic Melanoma
Research Committee(s)
Melanoma
Activated
08-01-2007
Closed
11-15-2009
Closed
Phase
Accrual
11%
Published
SWOG Clinical Trial Number
S0600

Phase III Trial of Irinotecan-Based Chemotherapy Plus Cetuximab (NSC-714692) or Bevacizumab (NSC-704865) as Second-Line Therapy for Patients with Metastatic Colorectal Cancer who have Progressed on Bevacizumab with either FOLFOX, OPTIMOX, or XELOX
Research Committee(s)
Gastrointestinal Cancer
Activated
06-15-2007
Closed
11-10-2010
ClinicalTrials.gov Registry Number
NCT00499369
Closed
Phase
Accrual
19%
Published
SWOG Clinical Trial Number
S0521

A Randomized Trial of Maintenance versus Observation for Patients with Previously Untreated Low and Intermediate Risk Acute Promyelocytic Leukemia (APL), Phase III
Research Committee(s)
Leukemia
Activated
06-01-2007
ClinicalTrials.gov Registry Number
NCT00492856
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0354

A Phase II Study of CNTO 328, A Monoclonal Antibody Against Interleukin-6 (IL-6) in Patients with Hormone Refractory Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
04-01-2007
Closed
05-15-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0622

Phase II Studies of Two Different Schedules of Dasatinib (NSC-732517) in Bone-Metastasis Predominant Metastatic Breast Cancer
Research Committee(s)
Breast Cancer
Activated
03-15-2007
Closed
12-15-2010